← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NUVO PHARMS INC · Approved 2011-09-19

Drug application

FDA Application #

ANDA091432

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN

Generic name

NAPROXEN

Active ingredients

NAPROXEN

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

NUVO PHARMS INC

Manufacturer

Cipla USA Inc.

First approval

2011-09-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown